JSJosé Dolores Solano

José Dolores Solano

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


José Dolores Solano has a total of 69 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Efficient modification of PAMAM G1 dendrimer surface with β-cyclodextrin units by CuAAC: impact on the water solubility and cytotoxicity

    by Kendra Sorroza-Martínez, Israel González-Méndez, Ricardo D. Martínez-Serrano, José D. Solano, Andrea Ruiu, Javier Illescas, Xiao Xia Zhu, Ernesto Rivera

    The toxicity of the poly(amidoamine) dendrimers (PAMAM) caused by the peripheral amino groups has been a limitation for their use as drug carriers in clinical applications. In this work, we completely modified the periphery of PAMAM dendrimer generation 1 (PAMAM G1) with β-cyclodextrin (β-CD) units through the Cu(I)-catalyzed azide–alkyne cycloaddition (CuAAC) to obtain the PAMAM G1-β-CD dendrimer with high yield. The PAMAM G1-β-CD was characterized by 1H- and 13C-NMR and mass spectrometry studies. Moreover, the PAMAM G1-β-CD dendrimer showed remarkably higher water solubility than native β-CD. Finally, we studied the toxicity of PAMAM G1-β-CD dendrimer in four different cell lines, human breast cancer cells (MCF-7 and MDA-MB-231), human cervical adenocarcinoma cancer cells (HeLa) and pig kidney epithelial cells (LLC-PK1). The PAMAM G1-β-CD dendrimer did not present any cytotoxicity in cell lines tested which shows the potentiality of this new class of dendrimers.


  • Conformational analysis by NMR and molecular dynamics of adamantane-doxorubicin prodrugs and their assemblies with β-cyclodextrin: A focus on the design of platforms for controlled drug delivery

    by Israel González-Méndez, Rodrigo Aguayo-Ortiz, Kendra Sorroza-Martínez, José D. Solano, Pasquale Porcu, Ernesto Rivera, Laura Dominguez


  • Open Access

    Differential behavior of NF‑κB, IκBα and EGFR during the renal carcinogenic process in an experimental model in vivo

    by Francisco Aguilar‑Alonso, Chabetty Vargas‑Olvera, Telma Pariente‑Pérez, José Dolores Solano, Patricia Curiel‑Muñiz, Carmen Adriana Mendoza‑Rodríguez, Daniela Tenorio‑Hernández, María Elena Ibarra‑Rubio

    Renal cell carcinoma (RCC) is the most common type of cancer of the adult kidney. It is generally asymptomatic even at advanced stages, so opportune diagnosis is rare, making it almost impossible to study this cancer at its early stages. RCC tumors induced by ferric nitrilotriacetate (FeNTA) in rats histologically correspond to the human clear cell RCC subtype (ccRCC) and the exposure to this carcinogen during either one or two months leads to different early stages of neoplastic development. High levels of nuclear factor kappa B (NF‑κB) and epidermal growth factor receptor (EGFR) as well as low levels of NF‑κB inhibitor alpha (IκBα) are frequent in human RCC, but their status in FeNTA‑induced tumors and their evolution along renal carcinogenesis is unclear. On this basis, in the present study NF‑κB, IκBα and EGFR behavior was analyzed at different stages of the experimental renal carcinogenesis model. Similar to patients with RCC, neoplastic tissue showed high levels of p65, one of the predominant subunits of NF‑κB in ccRCC and of EGFR (protein and mRNA), as well as a decrease in the levels of NF‑κB's main inhibitor, IκBα, resulting in a classic oncogenic combination. Conversely, different responses were observed at early stages of carcinogenesis. After one month of FeNTA‑exposure, NF‑κB activity and EGFR levels augmented; but unexpectedly, IκBα also did. While after two months, NF‑κB activity diminished, but EGFR and IκBα levels remained elevated. In conclusion, FeNTA‑induced tumors and RCC human neoplasms are analogues regarding to the classic NF‑κB, IκBα and EGFR behavior, and distinctive non‑conventional combination of changes is developed at each early stage studied. The results obtained suggest that the dysregulation of the analyzed molecules could be related to different signaling pathways and therefore, to particular effects depending on the phase of the carcinogenic process.


  • Optimized synthesis, characterization and in vitro systematic evaluation of adamantane-doxorubicin prodrugs sensitive to pH in breast cancer cells

    by Israel González-Méndez, José D. Solano, Pasquale Porcu, Andrea Ruiu, Yareli Rojas-Aguirre, Ernesto Rivera


  • Synthesis and Cytotoxic Activity of 2,6-Diarylidenecyclohexanones and their 6-Amino-1,3-dimethyluracil Monoadducts

    by Erika Madeleyne Ramos-Rivera, Cuauhtemoc Alvarado, Jose D. Solano, Luis Roa de la Fuente, Angeles Dominguez-Rivera, Miguel Angel Vilchis-Reyes, Miguel Angel Martinez-Urbina

    A series of 2,6-diarylidencyclohexanones, structural analogues of chalcones, was synthesized. These compounds showed cytotoxicity between 15.5 to 63.2 μM in HeLa, K562, MCF7, SW480 and C33 human cell lines. Compound 5 was the most active in K562 (IC50 15.5 μM) and C-33 (IC50 16.6 μM) cell lines. In contrast, when a 6-amino-1, 3-dimethyluracil group was added to 2,6-diarylidencyclohexanones, the activity was lost. In addition, we showed that compound 5 produces disruption in the cell cycle of HeLa cells.

  • Synthesis, cytotoxic activity, DNA binding and molecular docking studies of novel 9-anilinothiazolo[5,4-b]quinoline derivatives

    by Francisco J. Reyes-Rangel, A. Kémish López-Rodríguez, Laura V. Pastrana-Cancino, Marco. A. Loza-Mejía, José D. Solano, Rogelio Rodríguez-Sotres, Alfonso Lira-Rocha


  • MAPKs’ status at early stages of renal carcinogenesis and tumors induced by ferric nitrilotriacetate

    by Francisco A. Aguilar-Alonso, José D. Solano, Chabetty Y. Vargas-Olvera, Ignacio Pacheco-Bernal, Telma O. Pariente-Pérez, María Elena Ibarra-Rubio

    Renal cell carcinoma (RCC) is asymptomatic at early stages, and thus, initial diagnosis frequently occurs at advanced or even metastatic stages, leading to a high rate of mortality. Ferric nitrilotriacetate (FeNTA)-induced RCC model is a useful tool to analyze molecular events at different stages of the carcinogenesis process in vivo. MAPKs’ alterations seem to play an important role in the development and maintenance of human RCC tumors. Based on the above, p38α/β/γ, JNK1/2, and ERK1/2 statuses were studied at early stages of FeNTA-induced renal carcinogenesis (1 and 2 months of carcinogen treatment) as well as in tumor tissue. MAPKs showed distinct response along carcinogenesis process, either as total proteins and/or as their phosphorylated forms. While the increase in total and phospho-p38α/β levels became lower as carcinogenesis progressed, p38γ overexpression grew. Instead, total JNK2 diminished, but JNK1 was elevated at all studied times, and p-JNK1 levels increased at early stages, but not in tumors. In contrast, p-JNK2 rose at 2 months of treatment and in tumor tissue. Increased levels of p-ERK1/2 were observed at all stages analyzed. Very interestingly, at 1 and 2 months of FeNTA treatment, no alterations in MAPKs were found in liver or lung, where no primary tumors are induced with the scheme of FeNTA administration followed here. In conclusion, MAPKs’ behavior evolved differentially as renal carcinogenesis advanced, even among isoforms of the same family, but it did not change in other tissues. All this strongly suggests a role of these kinases in FeNTA-induced RCC tumor development and maintenance.


  • Characterization of N-diethylnitrosamine-initiated and ferric nitrilotriacetate-promoted renal cell carcinoma experimental model and effect of a tamarind seed extract against acute nephrotoxicity and carcinogenesis

    by Chabetty Y. Vargas-Olvera, Dolores Javier Sánchez-González, José D. Solano, Francisco A. Aguilar-Alonso, Fernando Montalvo-Muñoz, Claudia María Martínez-Martínez, Omar N. Medina-Campos, María Elena Ibarra-Rubio

    Renal cell carcinoma (RCC), the commonest malignancy in adult kidney, lacks of early signs, resulting often in metastasis at first diagnosis. N-Diethylnitrosamine (DEN)-initiated and ferric nitrilotriacetate (FeNTA)-promoted RCC may be a useful experimental model, but it is not well characterized. In this study, histological alterations and oxidative stress markers were analyzed at different times throughout RCC development, histological subtype was re-evaluated in the light of current classification, and a tamarind seed extract (TSE) effect was examined. Male Wistar rats experimental groups were control, TSE, DEN, DEN+FeNTA, and TSE+DEN+FeNTA. TSE was given 2 weeks before DEN administration (200 mg/kg) and throughout the experiment. Fourteen days after DEN treatment, two FeNTA doses (9 mg Fe/kg) for acute nephrotoxicity study, and increasing FeNTA doses (3–9 mg Fe/kg) twice a week for 16 weeks for carcinogenesis protocol, were administered. In acute study, necrosis and renal failure were observed and TSE ameliorated them. Throughout carcinogenesis protocol, preneoplastic lesions were observed since 1 month of FeNTA treatment, which were more evident at 2 months, when also renal cysts and RCC were already detected. RCC tumors were obtained without changes in renal function, and clear cell histological subtype was identified in all cases. 4-Hydroxy-2-nonenal and 3-nitro-l-tyrosine levels increased progressively throughout protocol. TSE decreased both oxidative stress markers and, although there was no statistical difference, it delayed RCC progress and decreased its incidence (21 %). This study brings an insight of the time course events in this carcinogenesis model, identifies clear cell subtype and establishes TSE renoprotective effects.


  • Antineoplastic activity of the thiazolo[5,4-b]quinoline derivative D3CLP in K-562 cells is mediated through effector caspases activation

    by Ignacio González-Sánchez, José D. Solano, Marco A. Loza-Mejía, Susana Olvera-Vázquez, Rogelio Rodríguez-Sotres, Julio Morán, Alfonso Lira-Rocha, Marco A. Cerbón


  • Coumarin A/AA induces apoptosis-like cell death in HeLa cells mediated by the release of apoptosis-inducing factor

    by Carolina Álvarez-Delgado, Ricardo Reyes-Chilpa, Elizabet Estrada-Muñiz, C. Adriana Mendoza-Rodríguez, Angelina Quintero-Ruiz, José Solano, Marco A. Cerbón

    It has been demonstrated that naturally occurring coumarins have strong biological activity against many cancer cell lines. In this study, we assessed the cytotoxicity induced by the naturally isolated coumarin A/AA in different cancer cell lines (HeLa, Calo, SW480, and SW620) and in normal peripheral‐blood mononuclear cells (PBMCs). Cytotoxicity was evaluated using the MTT assay. The results demonstrate that coumarin A/AA was cytotoxic in the four cancer cell lines tested and importantly was significantly less toxic in PBMCs isolated from healthy donors. The most sensitive cancer cell line to coumarin A/AA treatment was Hela. Thus, the programmed cell death (PCD) mechanism induced by this coumarin was further studied in this cell line. DNA fragmentation, histomorphology, cell cycle phases, and subcellular distribution of PCD proteins were assessed. The results demonstrated that DNA fragmentation, but not significant cell cycle disruptions, was part of the PCD activated by coumarin A/AA. Interestingly, it was found that apoptosis‐inducing factor (AIF), a proapoptotic protein of the mitochondrial intermembrane space, was released to the cytoplasm in treated cells as detected by the western blot analysis in subcellular fractions. Nevertheless, the active form of caspase‐3 was not detected. The overall results indicate that coumarin A/AA induces a caspase‐independent apoptotic‐like cell death program in HeLa cells, mediated by the early release of AIF and suggest that this compound may be helpful in clinical oncology. © 2009 Wiley Periodicals, Inc. J Biochem Mol Toxicol 23:263–272, 2009; Published online in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/jbt.20288